©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Polymerization of Recombinant Hb S-Kempsey (Deoxy-R State) and Hb S-Kansas (Oxy-T State) (*)

(Received for publication, June 1, 1995; and in revised form, August 2, 1995)

Kazuhiko Adachi (1)(§) Praveena Sabnekar (1) Megumi Adachi (1) Lattupally R. Reddy (1) Jian Pang (1) Konda S. Reddy (2) Saul Surrey (1)

From the  (1)Children's Hospital of Philadelphia, Division of Hematology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 and (2)Department of Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

In order to investigate the role of the R (relaxed) to T (tense) structural transition in facilitating polymerization of deoxy-Hb S, we have engineered and expressed two Hb S variants which destabilize either T state (Hb S-Kempsey, alpha(2)beta(2)) or R state structures (Hb S-Kansas, alpha(2)beta(2)). Polymerization of deoxy-Hb S-Kempsey, which shows high oxygen affinity and increased dimer dissociation, required about 2- and 6-fold higher hemoglobin concentrations than deoxy-Hb S for polymerization in low and high phosphate concentrations, and its kinetic pattern of polymerization was biphasic. In contrast, oxy- or CO Hb S-Kansas, which shows low oxygen affinity and increased dimer dissociation, polymerized at a slightly higher critical concentration than that required for polymerization of deoxy-Hb S in both low and high phosphate buffers. Polymerization of oxy- and CO Hb S-Kansas was linear and showed no delay time, which is similar to oversaturated oxy- or CO Hb S. These results suggest that nuclei formation, which occurs during the delay time prior to deoxy-Hb S polymerization, does not occur in T state oxy-Hb S-Kansas, even though the critical concentration for polymerization of T state oxy-Hb S-Kansas is similar to that of T state deoxy-Hb S.


INTRODUCTION

Oxygen binding has a dramatic effect on Hb S polymerization. Deoxygenated Hb S forms gels, while oxygenated Hb S does not(1) . The reason for this difference between oxy and deoxy forms of Hb S is the marked change in quaternary conformation of the hemoglobin molecule upon deoxygenation(2, 3) . When normal hemoglobin is fully deoxygenated, most of the molecules assume the T (^1)structure, which has a relatively low affinity for oxygen and other heme ligands. Conversely, normal oxyhemoglobin exists almost exclusively in the R conformation and has a relatively high affinity for heme ligands such as oxygen. Structural alterations that affect the equilibrium between T and R states are expected to have a marked effect on hemoglobin function as well as Hb S polymerization. X-ray crystallographic studies show that hemoglobin can assume two different quaternary structures: one characteristic of unliganded (T) and the other of liganded (R) hemoglobin(2) .

The key to Hb S polymerization is the presence of Val-beta6 and the formation of a hydrophobic acceptor pocket between E and F helices that occurs in the T state but is absent in the R state(3, 4) . However, if a specific amino acid substitution decreases stability of the T structure, then transition to the R state is favored and the molecule exhibits increased oxygen affinity and decreased heme-heme interaction. This has been demonstrated for a number of chemically modified hemoglobins as well as for many hemoglobin variants(3) . Hb Kempsey (alpha(2)beta(2)) and Hb Kansas (alpha(2)beta(2)) are well studied examples(3, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17) . Hb Kempsey is a beta-chain variant in which Asp-beta99 is replaced by Asn(5) . In deoxy-Hb A, Asp-beta99 normally forms an important hydrogen bond with Tyr-alpha42 at the alpha(1)beta(2) interface(11) . Upon oxygenation, the two subunits shift in a dovetail fashion, so that the beta99-alpha42 hydrogen bond is broken and another one forms between Asp-alpha94 and Asn-beta102. In Hb Kempsey, substitution of Asp with Asn at beta99 prevents formation of the former hydrogen bond with Tyr-alpha42 and therefore decreases stability of ``deoxy'' or T state structures. Thus, when this tetramer is fully deoxygenated, it remains partially in the R state.

In contrast, Hb Kansas is a beta-chain variant in which Asn-beta102 is replaced by Thr(14) . This position is also an important site at the alpha(1)beta(2) interface, which is involved in the transition between the oxy and deoxy conformation of hemoglobin. Hb Kansas has a low oxygen affinity because the hydrogen bond that usually occurs between Asn-beta102 and Asp-alpha94 in normal Hb A, which functions to stabilize the oxy conformation, is absent, thus shifting the equilibrium toward the deoxy (T) conformation(3, 12, 13, 18) .

Asp-beta99 and Asn-beta102 in Hb S are located internally at the alpha(1)beta(2) interface and are not exposed to the surface of tetrameric hemoglobin. These positions are involved in alphabeta interactions, which lead to formation of tetramers, and are not defined as interaction sites in Hb S polymers. These amino acids do affect the R to T quaternary structural transition of hemoglobin tetramers. In this report, we have studied polymerization of R state deoxy-Hb S and T state oxy or CO Hb S by preparing Hb S-Kempsey (alpha(2)beta(2)) and Hb S-Kansas (alpha(2)beta(2)) using a yeast expression system (19) in an attempt to clarify the role that quaternary structural changes associated with T to R state transition play in polymerization of Hb S.


MATERIALS AND METHODS

The plasmid pGS389 Hb S contains the full-length human alpha- and beta^S-globin cDNAs under transcriptional control of dual GGAP promoters as well as a partially functional yeast LEU2d gene and the URA3 gene for selection in yeast(19, 20) . The plasmid pGS189 beta^S contains a single GGAP promoter and beta^S-globin cDNA and was constructed by mutagenesis and subcloning as described previously(19) . The basic strategy for site-specific mutagenesis at beta99 or beta102 involves recombination polymerase chain reaction as described previously(19) . Asn-beta99 and Thr-beta102 beta^S-chain variants were subjected to DNA sequence analysis of the entire beta-globin cDNA using site-specific primers and fluorescently tagged terminators in a cycle sequencing reaction in which extension products were analyzed on an automated DNA sequencer(19) . The mutated beta-globin cDNA region was then excised by XhoI digestion and subcloned back into the XhoI site of the expression vector pGS389(19) .

Yeast growth, plasmid transformation, induction, and purification of recombinant hemoglobin tetramers were described previously(19, 20, 21) . Abnormal forms of the recombinant hemoglobins, which include sulfhaem-containing hemoglobin and/or misfolded hemoglobin, were eliminated by chromatographic purification(21) . The purified alpha- and beta-chains of the Hb S variants containing Asn-beta99 or Thr-beta102 were subjected to electrospray mass analysis (Fisons Instruments, VG Biotech, Altricham, UK) using the multiply charged ion peaks from the alpha-globin chain (M(r) = 15,126.4) as an external reference for mass scale calibrations(22) . Val-beta6 and N-terminal amino acid sequences of purified alpha- and beta-chains were directly confirmed by Edman degradation employing a pulsed liquid, protein sequencer (ABI 477A, Applied Biosystems, Inc., Foster City, CA). Absorption spectra of the purified hemoglobin variants were recorded using a Hitachi U-2000 spectrophotometer. Circular dichroism spectra of the variants were recorded using an Aviv model 62 DS instrument employing a 0.1-cm light path cuvette at 10 µM Hb concentrations. Methods for determination of oxygen dissociation curves and electrophoretic analysis of hemoglobins and their kinetics of polymerization in high phosphate buffers were performed as reported previously(19, 23) . Kinetics of polymerization and solubility of hemoglobins in 0.1 M phosphate buffer, pH 7.0, as well as measurements of minimum concentrations required for gel formation were performed as described previously with slight modification(24, 25) . The time course for the gelation of deoxy-Hb S in 0.1 M phosphate buffer, pH 7.0, at 30 °C was done by the temperature jump method by monitoring change in optical density at 800 nm using an anaerobic cylindrical cuvette with a 2-mm diameter. Solubility of deoxy-Hb S was measured by the determination of soluble deoxy-Hb S concentration after centrifugation at 30 °C for 3 h at 130,000 times g. Tetramer-dimer dissociation properties of hemoglobins were evaluated by monitoring fluorescence changes of haptoglobin using a Hitachi F-2000 fluorescence spectrophotometer (26) .


RESULTS

Characterization of Recombinant Hb S Variants Containing Asn-beta99 or Thr-beta102

Purified recombinant Hb S variants containing Asn-beta99 or Thr-beta102 (Hb S Dbeta99N and Hb S Nbeta102T, respectively) migrated as single bands following cellulose acetate electrophoresis at pH 8.6 with mobilities intermediate between Hb S and Hb C (Fig. 1). The beta99 Hb S variant demonstrated a higher positive surface charge than the beta102 Hb S variant and migrated closer to Hb C. It is interesting to note that isoelectric focusing of a recently reported recombinant Hb A variant containing Lys-beta99 made using the same yeast expression system showed two bands(26) , while both beta99 and beta102 Hb S variants in our study migrated as single bands on isoelectric focusing. The reason for the existence of two electrophoretic forms for the Hb A variant containing Lys-beta99 is not known(26) .


Figure 1: Electrophoretic mobilities of Hb S Dbeta99N and Hb S Nbeta102T. Electrophoretic mobilities of Hb S Dbeta99N (lane 4) and Hb S Nbeta102T (lane 5) were compared with native Hb A (lane 1), Hb S (lane 2), and Hb C (lane 3) following cellulose acetate electrophoresis.



Mass spectral analysis of Hb S variants containing Asn-beta99 or Thr-beta102 showed the expected beta-globin chain molecular masses, 15,835.1 and 15,823.8 Da, respectively, which corresponded to expected masses of 15,836 and 15,824 Da, respectively. Absorption spectra of these two Hb S variants were the same as those of native and recombinant Hb S(19) . Circular dichroism spectra in the region from 190 to 290 nm for the Hb S variants were also similar to that of native Hb S (Fig. 2), indicating that these substitutions do not significantly affect globin folding and/or overall secondary structure of hemoglobin tetramers.


Figure 2: Circular dichroism spectra of Hb S Dbeta99N and Hb S Nbeta102T. Spectra were recorded for the CO form of Hb S Dbeta99N and Hb S Nbeta102T (10 µM) in 0.1 M phosphate buffer, pH 7.0, at 5 °C, and results were corrected for small differences in protein concentration. A, B, and C represent Hb S, Hb S Dbeta99N, and Hb S Nbeta102T, respectively.



It is known that Hb Kempsey and Hb Kansas have higher and lower oxygen affinity than normal Hb A, respectively(6, 12) . Oxygen affinities of Hb S Dbeta99N and Hb S Nbeta102T differed from Hb S as anticipated; the former had higher and the latter lower oxygen affinity than Hb S or Hb A (Fig. 3). P values in 0.1 M phosphate buffer, pH 7.0, at 20 °C for the Asn-beta99 and Thr-beta102 Hb S variants were 0.8 and 18, respectively, compared with 6.5 for recombinant Hb S(19) . Hill coefficients for both variants were reduced to 1.2 and 1.5 for Hb S Dbeta99N and Hb S Nbeta102T, respectively, compared with 2.6 for Hb S (Table 1).


Figure 3: Oxygen equilibrium curves of Hb S Dbeta99N and Hb S Nbeta102T. Oxygen equilibrium curves of Hb S Dbeta99N (circle) and Hb S Nbeta102T (up triangle) were determined in 0.1 M phosphate buffer, pH 7.0, at 20 °C and compared with native human Hb S (times).





Differences in oxygen affinity for Hb S Dbeta99N and Hb S Nbeta102T compared with Hb S should be correlated with differences in kinetics of dimer formation as has been shown for deoxy-Hb Kempsey and oxy-Hb Kansas(6, 12) . Tetramer-dimer dissociation properties of the two Hb S variants were measured by monitoring quenching of haptoglobin fluorescence caused by existing hemoglobin dimers (Table 2). Deoxy-Hb S Nbeta102T showed similar dimer formation properties to that of deoxy-Hb S, while deoxy-Hb S Dbeta99N exhibited increased dimer formation. In contrast, oxy-Hb S Nbeta102T showed a slightly increased tendency, while oxy-Hb S Dbeta99N showed a similar tendency for dimer formation as oxy-Hb S.



Polymerization Properties of Recombinant Hb S Variants Containing Asn-beta99 or Thr-beta102

Polymerization properties of the deoxy forms of the two Hb S variants were studied in vitro by the temperature jump method employing 1.8 M phosphate buffer, pH 7.4, at 30 °C(23) . Polymerization of deoxy-Hb S is characterized by a delay time prior to polymer formation whose length depends on hemoglobin concentration: the lower the concentration, the longer the delay time(23) . Deoxy (T) structure of Hb Kempsey (alpha(2)beta(2)) is destabilized by the Asn for Asp substitution at beta99, which results in Hb Kempsey remaining partially in the R state upon deoxygenation(3, 6) . Deoxy-Hb S Dbeta99N was deoxygenated in the presence of more than 100-fold excess Na(2)S(2)0(4) after exposure to nitrogen(23) . The optical absorption spectrum of deoxygenated Hb S Dbeta99N was characteristic of hemoglobin in the deoxy form. Deoxy-Hb S Dbeta99N required about a 6-fold higher hemoglobin concentration than deoxy-Hb S for polymerization. At higher concentrations (more than 10-fold that of deoxy-Hb S), deoxy-Hb S Dbeta99N polymerization occurred without a delay time by a linear and not a nucleation-controlled mechanism (Fig. 4). At lower hemoglobin concentrations (<330 mg/dl), kinetics of polymerization of deoxy-Hb S Dbeta99N were biphasic, occurred without a delay time, reached a plateau, and then continued following sigmoidal kinetics (Fig. 4). Furthermore, the time required to reach the plateau of the second phase of polymer formation was longer than that of the first. Logarithmic plots of the initiation time for the second phase of polymerization for deoxy-Hb S Dbeta99N versus hemoglobin concentration showed a straight line (Fig. 5), and polymerization was reversed after exposure to CO or by lowering the temperature to 0 °C. We also performed gelation studies of deoxy-Hb S Dbeta99N in 0.1 M phosphate buffer in order to assess polymerization properties near more physiological conditions. Under these conditions, deoxy-Hb S Dbeta99N required about a 2-fold higher (47 g/dl) concentration than deoxy-Hb S for polymerization (Table 3).


Figure 4: Kinetics of polymerization for deoxy-Hb S Dbeta99N. The time course of polymerization for deoxy-Hb S Dbeta99N was defined using 1.8 M phosphate buffer, pH 7.4, at 30 °C by the temperature jump method. a, b, and c represent 506, 432, and 332 mg/dl deoxy-Hb S Dbeta99N, respectively.




Figure 5: Relationship between log of reciprocal delay time and hemoglobin concentration. Polymerization studies of hemoglobins at different concentrations were performed in 1.8 M phosphate buffer, pH 7.4, at 30 °C. bullet, up triangle, and box refer to native deoxy-Hb S, deoxy-Hb S Dbeta99N, and deoxy-Hb S Nbeta102T, respectively.





In contrast to Hb Kempsey, the deoxy form of Hb S Nbeta102T (Hb S-Kansas) polymerized like deoxy-Hb S (Fig. 6); however, a small amount of detectable polymers formed prior to the major phase of polymerization. Logarithmic plots of delay time versus hemoglobin concentration for the major phase of deoxy-Hb S Nbeta102T polymerization showed a straight line slightly shifted to the right of the line for deoxy-Hb S (Fig. 5). It is known that the oxy structure is destabilized in Hb Kansas, which favors the low oxygen affinity T (deoxy) state(3, 12) . Polymerization of liganded oxy- and CO-Hb S-Kansas occurred at a slightly higher concentration than that required for deoxy-Hb S polymerization; however, polymer formation was not accompanied by a delay time prior to polymerization, and oxy-Hb S Nbeta102T polymerized linearly like oxy- and CO-Hb S (27) (Fig. 7). A hemoglobin concentration 20 times less than that for oxy-Hb S was, however, required to initiate polymerization. The CO form of Hb S Nbeta102T also polymerized linearly like the oxy form(27) . Polymerization of oxy, CO, and deoxy-Hb S Nbeta102T was reversed by decreasing the temperature to 0 °C; however, when deoxy-Hb S Nbeta102T polymers were exposed to CO, about 60% of the polymers depolymerized (Fig. 8) in contrast to complete depolymerization for deoxy-Hb S polymers(19) . It is noteworthy that polymerization of oxy-Hb S Nbeta102T in 1.8 M phosphate buffer was not affected by addition of inositol hexaphosphate, even though organic phosphates are known to stabilize the T state of liganded Hb Kansas(18) .


Figure 6: Kinetics of polymerization for deoxy-Hb S Nbeta102T. The time course of polymerization for the deoxy form of Hb S Nbeta102T was defined using 1.8 M phosphate buffer, pH 7.4, at 30 °C by the temperature jump method as described previously. a and b represent 97.2 and 81 mg/dl deoxy-Hb S Nbeta102T, respectively.




Figure 7: Kinetics of polymerization for Hb S Nbeta102T in the oxy form. The time course of polymerization for the oxy form of Hb S Nbeta102T was defined using 1.8 M phosphate buffer, pH 7.4, at 30 °C by the temperature jump method. a and b represent 243 and 162 mg/dl oxy-Hb S Nbeta102T, respectively.




Figure 8: Depolymerization of deoxy-Hb S Nbeta102T. Depolymerization of deoxy-Hb S Nbeta102T (98 mg/dl) polymers in 1.8 M phosphate buffer, pH 7.4, at 30 °C was evaluated after exposure to CO and cooling the temperature to 0 °C.



We also evaluated gelation and polymerization of CO Hb S Nbeta102T at room temperature in low phosphate concentration (0.1 M) buffer, pH 7.0, under more physiological conditions. CO Hb S Nbeta102T formed gels at a concentration of 25.7 g/dl compared with 24 g/dl for deoxy-Hb S and 24.5 g/dl for deoxy-Hb S (Table 2). CO Hb S Nbeta102T polymerized linearly without a delay time in 0.1 M phosphate buffer, pH 7.0, at 30 °C (Fig. 9), which is similar to results in 1.8 M phosphate buffer (Fig. 7). Solubility after polymerization of CO Hb S Nbeta102T in 0.1 M phosphate buffer, pH 7.0, at 30 °C was 19.2 versus 17 g/dl for deoxy-Hb S. Depolymerization of CO Hb S Nbeta102T in low phosphate buffer was also observed upon lowering the temperature to 0 °C.


Figure 9: Kinetics of polymerization for Hb S Nbeta102T in the CO form in low phosphate buffer. Time course of polymerization for the CO form of Hb S Nbeta102T was defined using 0.1 M phosphate buffer, pH 7.0, at 30 °C by the temperature jump method. a and b represent 26 and 22 g/dl CO Hb S Nbeta102T, respectively.



Total polymer formed in 1.8 M phosphate buffer as a function of hemoglobin concentration was also determined in order to evaluate effects of the Asn-beta99 and Thr-beta102 substitutions on the critical concentrations required for polymerization. Critical concentration depends on deoxyhemoglobin solubility: the higher the solubility, the higher the concentration required for polymerization. Polymer formation for the two variants increased linearly with increases in initial hemoglobin concentration (Fig. 10). Critical concentration for polymer formation was then determined by extrapolation of the lines to zero turbidity(19) . Values for deoxy-Hb S, CO Hb S, and deoxy-Hb S were 1.2-, 1.6-, and 6.3-fold higher, respectively, than that for deoxy-Hb S.


Figure 10: Polymer formation as a function of hemoglobin concentration. Turbidity at the plateau of the polymerization curves in 1.8 M phosphate buffer at various hemoglobin concentrations was measured at 700 nm. bullet, up triangle, , and box refer to native deoxy-Hb S, deoxy-Hb S Dbeta99N, deoxy-Hb S Nbeta102T, and oxy-Hb S Nbeta102T, respectively.




DISCUSSION

The functional properties of normal Hb A and polymerization of Hb S depend on transition of their three-dimensional conformation, which accompanies the addition and removal of oxygen. X-ray crystallographic studies show that hemoglobin tetramers exist in equilibrium between two quaternary conformations: R and T(2, 11) . The change from T to the R conformation involves a well defined series of structural changes, including rupture of the salt bridges that stabilize the T conformation and rotation of the beta-chains relative to the alpha-chains(3, 11) . Intramolecular ``movements'' also occur during conformational isomerization at the alpha(1)beta(2) interface. Structural alterations that affect the equilibrium between R and T states are expected to have marked effects on hemoglobin function and Hb S polymerization. Thus, if a specific amino acid substitution decreases T structure stability, then transition to the R state would be expected to occur at an earlier stage in ligation, and this hemoglobin would exhibit increased oxygen affinity and decreased heme-heme interaction. In contrast, substitutions that decrease R structure stability result in tetramers with decreased oxygen affinity and increased heme-heme interaction. These results have been observed for a number of hemoglobin variants. Both Hb Kempsey and Hb Kansas, which have amino acid substitutions at the alpha(1)beta(2) interface, are well studied examples(5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18) . In most respects, deoxy-Hb Kempsey with high oxygen affinity bears more resemblance to oxyhemoglobin A than to deoxyhemoglobin A and is partially in the R conformation(6, 7, 8) . Recombinant Hb S-Kempsey exhibited high oxygen affinity with low cooperativity. Polymerization of deoxy-Hb S-Kempsey occurred at higher concentrations than deoxy-Hb S, and kinetic studies suggested polymerization by linear as well as nucleation-controlled mechanisms (19, 27) . These results suggest that Hb S-Kempsey is not completely converted to the R state upon deoxygenation. Asp-beta99 is located in the interior of Hb S, but yet the change from Asp-beta99 to Asn in Hb S-Kempsey inhibits polymerization, no doubt by affecting the quaternary structure. These results indicate that inhibition and/or acceleration of polymerization of Hb S is not always controlled by residues at direct interaction sites of deoxy-Hb S polymers. We are now attempting to define effects of this substitution at the allosteric interface of Hb S on polymer and crystal structure.

Hb Kansas contains Thr instead of Asp at beta102, which is also a site at the alpha(1)beta(2) interface (3, 12) . However, in contrast to Hb Kempsey, Hb Kansas has decreased oxygen affinity, which is due in part to a relatively unstable R structure, thereby shifting the equilibrium to that of the T structure. Our results with Hb S-Kansas showed low oxygen affinity, and liganded forms had decreased solubility, thereby facilitating polymerization like deoxy-Hb S. The critical concentrations for polymerization of liganded forms of Hb S-Kansas were similar to the deoxy form of Hb S-Kansas. Facilitation of polymerization of liganded hemoglobin can be explained by shifting conformational equilibrium to favor the T state like Hb Kansas. However, the kinetics of polymerization of liganded Hb S-Kansas were different from those of deoxy-Hb S and deoxy-Hb S-Kansas, which were accompanied with a delay time prior to polymerization. These results suggest that the surface structure of liganded Hb S-Kansas resembles that of the T structure of Hb A or Hb S. The lack of nucleation during polymerization of oxy or CO Hb S-Kansas, even though the T-state is favored, may be caused by insufficient protein-protein interactions that are required to form deoxy-Hb S or deoxy-Hb S-Kansas nuclei.

There are seven known natural hemoglobin variants with substitutions for Asp-beta99(5, 6, 26, 28, 29, 30, 31, 32, 33, 34) . Recently, recombinant Hb A containing Asp-beta99 Lys and a double mutant (Asp-beta99 Asn and Tyr-alpha42 Asp), which were produced in yeast and Escherichia coli expression systems, respectively, were characterized(26, 35) . All these variants show increased oxygen affinity with reduced cooperativity. There are also three known natural hemoglobin variants with substitutions at beta102, and recombinant Hb A Dbeta102A made in yeast was also recently reported(36, 37, 38) . These variants show decreased oxygen affinity with reduced cooperativity. Functional properties of hemoglobin variants with substitutions at beta99 and beta102, which involve the alpha(1)beta(2) contact, have been attributed to increased dissociation of the variant tetrameric hemoglobin dimers. Deoxy-Hb S-Kempsey and oxy-Hb S-Kansas show increased dissociation to dimers like Hb Kempsey and Hb Kansas(6, 12) . Recent studies of recombinant Hb A Dbeta99K and Hb A Nbeta102A indicated that dimerization properties of these variants depended on hemoglobin concentration: the higher the concentration, the lower the tetramer-dimer dissociation constant of hemoglobin(26, 38) . Although polymerization properties of dimeric forms of Hb S are not known, the effect of dimerization on polymerization of Hb S-Kansas and Hb S-Kempsey should be negligible, since hemoglobin concentrations used for polymerization in both high and low phosphate buffers (50-100 µM and 1.5-6 mM, respectively) are too high to favor dimer formation. Polymerization properties of oxy- or CO Hb S-Kansas and deoxy-Hb S-Kempsey in low and high phosphate buffers can therefore be attributed to the quaternary and tertiary structural differences from deoxy-Hb S rather than dimerization differences. It is interesting to note that deoxy-Hb Kansas crystallizes like deoxy-Hb A and that exposure of these crystals to CO results in formation of two new crystal forms that are not identical to crystals formed upon deoxygenation(15) . In contrast, deoxy-Hb A crystals dissolve upon exposure to CO. These results are similar to those of exposure of deoxy-Hb S-Kansas polymers to CO. Polymers of CO Hb S-Kansas may also remain in the T state conformation, which may not favor CO-induced depolymerization. Structural analyses of these Hb S variants are now required to further our understanding of the relationship between quaternary structure, hemoglobin function, and polymerization of Hb S.


FOOTNOTES

*
This research was supported by National Institutes of Health Grant HL38632 and by a grant from the American Heart Association (Southeastern Pennsylvania Affiliate). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Division of Hematology, Children's Hospital of Philadelphia, 34th St. & Civic Center Blvd., Philadelphia, PA 19104. Tel.: 215-590-3576; Fax: 215-590-4834.

(^1)
The abbreviations used are: T, tense; R, relaxed.


ACKNOWLEDGEMENTS

We thank Dr. Eric Rappaport and members of the Nucleic Acid/Protein Core at the Children's Hospital of Philadelphia for oligonucleotide syntheses, protein characterization, and automated DNA sequence analysis. We are also grateful to Dr. E. W. Witkowska for mass spectral analysis of the Hb S variants performed at the Children's Hospital Mass Spectrometry Facility in Oakland, CA (Dr. C. Shackleton, director), which is supported in part by National Institutes of Health Grant HL20985 and Shared Instrumentation Grant RR06505 from National Institutes of Health.


REFERENCES

  1. Harris, J. W. (1950) Proc. Soc. Exp. Biol. Med. 75, 197-201
  2. Perutz, M. F. (1970) Nature 288, 726-739
  3. Bunn, H. F., and Forget, B. (1986) Hemoglobin: Molecular, Genetic and Clinical Aspects , pp. 452-564, W. B. Saunders, Philadelphia
  4. Dickerson, R. E., and Geis, I. (1983) Hemoglobin: Structure, Function, Evolution and Pathology , pp. 125-164, The Benjamin/Cummings Publishing Co., Inc., Menlo Park, CA
  5. Reed, C. S., Hampson, R., Gordon, S., Jones, R. T., Novy, M. J., Brimhall, B., Edwards, M. J., and Koler, R. D. (1968) Blood 31, 623-632 [Medline] [Order article via Infotrieve]
  6. Bunn, H. F., Wohl, R. C., Bradley, T. B., Cooley, M., and Gibson, Q. H. (1974) J. Biol. Chem. 249, 7402-7409 [Abstract/Free Full Text]
  7. Lindstrom, T. R., Baldassare, J. J., Bunn, H. F., and Ho, C. (1973) Biochemistry 12, 4212-4217 [Medline] [Order article via Infotrieve]
  8. Perutz, M. F., Ladner, J. E., Simon, S. R., and Ho, C. (1974) Biochemistry 13, 2163-2173 [Medline] [Order article via Infotrieve]
  9. Perutz, M. F., Fersht, A. R., Simon, S. R., and Roberts, G. C. K. (1974) Biochemistry 13, 2174-2186 [Medline] [Order article via Infotrieve]
  10. Nagai, K., La Mar, G. N., Jue, T., and Bunn, H. F. (1982) Biochemistry 21, 842-847 [Medline] [Order article via Infotrieve]
  11. Perutz, M. F., and Ten Eyck, L. F. (1971) Cold Spring Harbor Symp. Quant. Biol. 36, 295-310
  12. Bonventura, J., and Riggs, A. (1968) J. Biol. Chem. 243, 980-991 [Abstract/Free Full Text]
  13. Gibson, Q. H., Riggs, A., amd Imamura, T. (1973) J. Biol. Chem. 248, 5976-5986 [Abstract/Free Full Text]
  14. Greer, J. (1971) J. Mol. Biol. 59, 99-105 [Medline] [Order article via Infotrieve]
  15. Anderson, L. (1975) J. Mol. Biol. 94, 33-49 [Medline] [Order article via Infotrieve]
  16. Atha, D. H., and Riggs, A. (1976) J. Biol. Chem. 251, 5537-5543 [Abstract]
  17. Atha, D. H., Johnson, M. L., and Riggs, A. F. (1979) J. Biol. Chem. 254, 12390-12398 [Medline] [Order article via Infotrieve]
  18. Ogawa, S., Mayer, A., and Shulman, R. G. (1972) Biochem. Biophys. Res. Commun. 49, 1485-1491 [Medline] [Order article via Infotrieve]
  19. Adachi, K., Konitzer, P., Kim, J., Welch, N., and Surrey, S. (1992) J. Biol. Chem. 268, 21650-21656 [Abstract/Free Full Text]
  20. Wagenbach, M., O'Rourke, K., Vitez, L., Wieczorek, A., Hoffman, S., Dufee, S., Tedesco, J., and Stetler, G. L. (1991) Bio/Technology 9, 57-61 [Medline] [Order article via Infotrieve]
  21. Adachi, K., Konitzer, P., Lai, C. H., Kim, J., and Surrey, S. (1992) Protein Eng. 5, 807-810 [Abstract]
  22. Shackleton, C. H., and Witkowska, H. E. (1994) in Mass Spectrometry: Clinical and Biomedical Applications (Desiderio, D. M., ed) Vol. 2, pp. 135-199, Plenum Press, New York
  23. Adachi, K., and Asakura, T. (1979) J. Biol. Chem. 254, 12273-12276 [Medline] [Order article via Infotrieve]
  24. Hofrichter, J., Ross, P. D., and Eaton, W. (1976) Proc. Natl. Acad. Sci. U. S. A. 73, 3035-3039 [Abstract]
  25. Richard, A. J., Mehanna, A. S., and Abraham, D. J. (1991) Hemoglobin 15, 125-128 [Medline] [Order article via Infotrieve]
  26. Yanase, H., Cahill, S., Martin De LLano, J. J., Manning, L. R., Schneider, K., Chait, B. T., Vandegriff, K. D., Winslow, R. M., and Manning, J. M. (1994) Protein Sci. 3, 1213-1223 [Abstract/Free Full Text]
  27. Adachi, K., and Asakura, T. (1981) J. Biol. Chem. 256, 1824-1830 [Abstract/Free Full Text]
  28. Jones, R. T., Osgood, E. E., Brimhall, B., and Koler, R. D. (1967) J. Clin. Invest. 46, 1840-1847 [Medline] [Order article via Infotrieve]
  29. Weatherall, D. J., Clegg, J. B., Callender, S. T., Wells, R. M. G., Gale, R. E., Huehns, E. R., Perutz, M. F., Viggiano, G., and Ho, C. (1977) Br. J. Haematol. 35, 177-191 [Medline] [Order article via Infotrieve]
  30. Rucknagel, D. L., Glynn, K. P., and Smith, J. R. (1967) Clin. Res. 15, 270
  31. Blouquit, Y., Braconnier, F., Galacteros, F., Arous, N., Soria, J., Zittoun, R., and Rosa. J. (1981) Hemoglobin 5, 19-31 [Medline] [Order article via Infotrieve]
  32. Rochette, J., Poyart, C., Varet, B., and Wajcman, H. (1984) FEBS Lett. 32, 6411-6418
  33. Tamagnini, G. P., Ribeiro, M. L., Valente, V., Ramachandran, M., Wilson, J. B., Baysal, E., Gu., L. H., and Huisman, T. H. J. (1991) Hemoglobin 15, 487-496 [Medline] [Order article via Infotrieve]
  34. Wajcman, H., Kister, J., Vasseur, C., Blouquit, Y., Behnken, J. L., and Galacteros, F. (1991) Blood 78, 206 (abstr.)
  35. Kim, H., Shen, J., Sun, D. P., Ho, N., Madrid, M., Tam, M. F., Zou, M., Cottam, P. F., and Ho, C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11547-11551 [Abstract/Free Full Text]
  36. Nagel, R., Lynfield, J., Johnson, J., Landau, L., Bookchin, R. M., and Harris, M. B. (1976) N. Engl. J. Med. 295, 125-130 [Abstract]
  37. Arous, N., Braconnier, F., Thillet, J., Blouquit, Y., Galacteros, F., Chevrier, M., Bordahandy, C., and Rosa, J. (1981) FEBS Lett. 126, 114-116 [CrossRef][Medline] [Order article via Infotrieve]
  38. Yanase, H., Manning, L. R., Vandegriff, K., Winslow, R. M., and Manning, J. M. (1995) Protein Sci. 4, 21-28 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.




This Article
Abstract
Full Text (PDF)
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Adachi, K.
Articles by Surrey, S.
Articles citing this Article
PubMed
PubMed Citation
Articles by Adachi, K.
Articles by Surrey, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.